Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer. This pilot project for colorectal cancer is part of VICC’s Personalized Cancer Medicine Initiative (PCMI), a program to identify genetic mutations in a patient’s tumor that may be useful in matching the appropriate therapy with each patient. […]
News: Personalized Cancer MedicineNext Page »
A recent explosion in technological advances has created a new field known as translational “omics” that allows the measurement of molecules within a tissue or cell — genomics investigates DNA and proteomics examines proteins. These new omics-based tests may be used to guide patient therapy in the future. Such omics-based tests are much more complex […]
Vanderbilt-Ingram Cancer Center physician-scientists who created the new online medical decision support tool called “My Cancer Genome” have been named winners of a $20,000 health care technology award sponsored by the National Cancer Institute. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” was presented as part of […]
Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA). Sosman is among the Dream Team’s principal investigators who will work closely to write the genomic-driven clinical trials and […]
For decades, cancers have been treated based on how they look under a microscope. Now, researchers know that specific abnormalities in the DNA of tumor cells can make each person’s cancer respond differently to treatment — knowledge that offers an exciting new avenue for tailored therapy. Personalizing cancer treatment for an individual patient based on […]
Dr. William Pao, director of hematology and oncology at Vanderbilt-Ingram Cancer Center, explains what personalized cancer medicine means for the future of lung cancer treatment. Learn more about Personalized Cancer Medicine.
Dr. Carlos Arteaga, director of the Vanderbilt-Ingram Cancer Center’s breast cancer program, describes how advances in personalized cancer medicine contributes to breast cancer treatment.
William Pao, M.D., Ph.D., associate professor of Medicine and director of Personalized Cancer Medicine at Vanderbilt, has been named director of the Division of Hematology and Oncology in the Department of Medicine. “Dr. Pao has demonstrated tremendous leadership and creativity since arriving at Vanderbilt,” said Nancy Brown, M.D., chair and physician-in chief of the Department […]
Breast cancer patients at Vanderbilt-Ingram Cancer Center can now have their tumor tissue tested for gene mutations that are important for treatment decisions. Information from genetic tests in the tumors will be used to match patients to the best cancer therapies available, including drugs that are in early clinical trial testing. Tumor mutation testing for […]
May is National Cancer Research Month, and Vanderbilt-Ingram Cancer Center would like to take the opportunity to celebrate the hard work and dedication of scientists and researchers here and around the world. Jennifer A. Pietenpol, Ph.D., the Cancer Center’s director, said celebrating this observance is a way to advocate to the public about the importance […]